S. Ashley

No ORCID on file · 3 papers in corpus
other 1994
Endometrial cancer during tamoxifen treatment
The Lancet ·doi:10.1016/s0140-6736(94)90103-1
nonrandomized-trial 1990
Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer
European journal of cancer (Oxford, England : 1990) ·doi:10.1016/0277-5379(90)90162-m

Seventy-four post-menopausal women with metastatic breast cancer were treated with a combination hormonal regimen consisting of tamoxifen, aminoglutethimide danazol and medroxyprogesterone acetate (POND). 72% of the patients had received no…

rct 1984
Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially
The Lancet ·doi:10.1016/s0140-6736(84)91872-5

222 patients with disseminated breast cancer have been randomised to receive either a combination of hormone therapies using tamoxifen, aminoglutethimide with hydrocortisone, and danazol (TAD), or tamoxifen alone. The response to the combin…